ARKG
ARK Genomic Revolution ETF (ETF)
—
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
$53.17
$-1.05 (-1.94%)
Price History
52-Week Range
Sign in to add ARKG to a watchlist or set price alerts.
Fundamentals
| Market Cap | - |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | - |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | - |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | ETF |
Technical Indicators
| RSI (14) | 77.2 |
| Beta | - |
| SMA 20 | $50.06 |
| SMA 40 | $48.11 |
| 52-Week High | $55.30 |
| 52-Week Low | $24.60 |
| 50-Day Avg | $45.98 |
| 200-Day Avg | $35.12 |
| Avg Volume | $3.56M |
| Volume | $3.85M |
Performance Analysis
NEUTRALARKG presents a mixed picture with both positive and negative indicators.
-
Trading near its 52-week high ($55.30), which may indicate limited upside.
-
RSI at 77.2 indicates overbought conditions — a pullback may be due.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
Recent News
Loading news...
Last updated: Oct 01, 2026 21:01 UTC
Back to Screener Export Report